Changing the treatment paradigm of hyperkalaemia management to enable and optimise renin-angiotensin-aldosterone system inhibitor (RAASi) therapy.

28 August 2017 (12:55 - 13:15)
Organised by:
Congress Presentation Part of: Hyperkalaemia and iron deficiency: how too much or too little may affect the heart Heart failure, other Open Access ESC Congress 2017